Authors: GUILLET P LASCOLA B BAGARRYLIEGEY D LORVELLEC K MARTIN N NICOARA A BACIUCHKA M DUFFAUD F CARISSIMI P COHEN P DELORME J CARLE G BRAGUER D QUILICHINI F CREVAT A FAVRE R

Citation: P. Guillet et al., CLINICAL PILOT-STUDY ON REPEATED SYSTEMAT ICALLY USE OF HEPARIN, VANCOMYCIN AND COLIMYCIN LOCKED FLUSH SOLUTION FOR CENTRAL INTRAVENOUS TOTALLY IMPLANTED CATHETER IN CANCEROLOGY, Pathologie et biologie, 45(6), 1997, pp. 506-513

Authors: GUILLET P MONJANEL S NICOARA A DUFFAUD F LACARELLE B BAGARRYLIEGEY D DURAND A CATALIN J FAVRE R

Citation: P. Guillet et al., A BAYESIAN DOSING METHOD FOR CARBOPLATIN GIVEN BY CONTINUOUS-INFUSIONFOR 120 H, Cancer chemotherapy and pharmacology, 40(2), 1997, pp. 143-149

Authors: BAGARRYLIEGEY D NICOARA A DUFFAUD F GUILLET P PIGNON T CATALIN J DURAND A FAVRE R

Citation: D. Bagarryliegey et al., INDIVIDUAL DOSAGE ADJUSTMENT OF HIGH-DOSE METHOTREXATE IN CLINICAL-PRACTICE, La Revue de medecine interne, 17(8), 1996, pp. 689-698